557 related articles for article (PubMed ID: 33815272)
1. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
2. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
4. New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency.
Zhu C; Luo W; Li Z; Zhang X; Hu J; Zhao S; Jiao X; Qin Y
Fertil Steril; 2021 Feb; 115(2):455-462. PubMed ID: 33041054
[TBL] [Abstract][Full Text] [Related]
5. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Microbiota Changes in Patients With Premature Ovarian Insufficiency and Its Correlation With Ovarian Function.
Wen J; Feng Y; Yan W; Yuan S; Zhang J; Luo A; Wang S
Front Endocrinol (Lausanne); 2022; 13():824282. PubMed ID: 35273569
[TBL] [Abstract][Full Text] [Related]
7. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
8. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
9. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
[TBL] [Abstract][Full Text] [Related]
10. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
11. Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?
Wen J; Huang K; Du X; Zhang H; Ding T; Zhang C; Ma W; Zhong Y; Qu W; Liu Y; Li Z; Deng S; Luo A; Jin Y; Zhang J; Wang S
Front Endocrinol (Lausanne); 2021; 12():626534. PubMed ID: 33935966
[TBL] [Abstract][Full Text] [Related]
12. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
Alebic MŠ; Stojanovic N; Dewailly D
Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
[TBL] [Abstract][Full Text] [Related]
13. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
14. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
[TBL] [Abstract][Full Text] [Related]
15. Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency.
Sahmay S; Usta TA; Erel T; Atakul N; Aydogan B
Climacteric; 2014 Apr; 17(2):197-203. PubMed ID: 24299186
[TBL] [Abstract][Full Text] [Related]
16. Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.
Guzel Y; Aba YA; Yakin K; Oktem O
PLoS One; 2017; 12(11):e0188334. PubMed ID: 29176793
[TBL] [Abstract][Full Text] [Related]
17. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency.
Falorni A; Brozzetti A; Aglietti MC; Esposito R; Minarelli V; Morelli S; Sbroma Tomaro E; Marzotti S
Clin Endocrinol (Oxf); 2012 Sep; 77(3):453-8. PubMed ID: 22417127
[TBL] [Abstract][Full Text] [Related]
18. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
19. Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.
Kasahara Y; Osuka S; Bayasula ; Nakanishi N; Murase T; Nakamura T; Goto M; Kotani T; Iwase A; Kikkawa F
Reprod Sci; 2021 Jan; 28(1):31-36. PubMed ID: 32737737
[TBL] [Abstract][Full Text] [Related]
20. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters.
Venturella R; Lico D; Sarica A; Falbo MP; Gulletta E; Morelli M; Zupi E; Cevenini G; Cannataro M; Zullo F
J Ovarian Res; 2015 Apr; 8():21. PubMed ID: 25881987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]